Glycation: a new hope in targeting hepatocellular carcinoma?

: Hepatocellular carcinoma (HCC) is the second most common cause of cancer mortality worldwide and is the most rapidly growing indication for liver transplantation globally. There is, therefore, an urgent need to explore novel areas which may be contributing to pathogenesis such as advanced glycation pathways, to better understand HCC progression. Advanced glycation end-products (AGEs) are a group of biologically active compounds that are formed...